Africa (WHO region) vs Guinea-Bissau: Meningococcal A conjugate (MENGA) vaccine immunization coverage (%)

Africa (WHO region)
27.0%
in 2025
Guinea-Bissau
65.0%
in 2025
Africa (WHO region) rank
5th
Guinea-Bissau rank
8th

Meningococcal A conjugate (MENGA) vaccine immunization coverage (%) over time

  • Africa (WHO region)
  • Guinea-Bissau
0204060201620202025

How they compare

Guinea-Bissau currently reports 65.0% against 27.0% in Africa (WHO region), a difference of 38.0%.

That makes Guinea-Bissau's figure about 2.4 times Africa (WHO region)'s.

The two have swapped places 2 times across 10 shared years of data; in 2016 it was Guinea-Bissau ahead.

Africa (WHO region) ranks 5th and Guinea-Bissau ranks 8th of 7 groups.

Across the 2 decades both report, Africa (WHO region) averaged higher in 1 and Guinea-Bissau in 1.

Head to head by decade

Decade Africa (WHO region) Guinea-Bissau Difference Ahead
2010s 8.8% 0.0% 8.8% Africa (WHO region)
2020s 25.7% 28.3% 2.7% Guinea-Bissau

Averages of every year both report within each decade.

Frequently asked questions

Which has higher meningococcal a conjugate (menga) vaccine immunization coverage (%), Africa (WHO region) or Guinea-Bissau?
Guinea-Bissau, at 65.0% against 27.0% in Africa (WHO region) as of 2025.
What is the difference in meningococcal a conjugate (menga) vaccine immunization coverage (%) between Africa (WHO region) and Guinea-Bissau?
38.0%, with Guinea-Bissau ahead.
How many years of comparable data are there for Africa (WHO region) and Guinea-Bissau?
10 years are reported by both, from 2016 to 2025.
How do Africa (WHO region) and Guinea-Bissau rank globally for meningococcal a conjugate (menga) vaccine immunization coverage (%)?
Africa (WHO region) ranks 5th and Guinea-Bissau ranks 8th of 7 groups.
Where does this data come from?
World Health Organization, Global Health Observatory, published as Meningococcal A conjugate (MENGA) vaccine immunization coverage (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Africa (WHO region) vs Guinea-Bissau: Meningococcal A conjugate (MENGA) vaccine immunization coverage (%). Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 14 September 2026, from https://health.statizoid.com/compare/meningococcal-a-conjugate-menga-vaccine-immunization-coverage-percent-wuenic/africa-who-region/guinea-bissau/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/meningococcal-a-conjugate-menga-vaccine-immunization-coverage-percent-wuenic/africa-who-region/guinea-bissau/">Africa (WHO region) vs Guinea-Bissau: Meningococcal A conjugate (MENGA) vaccine immunization coverage (%)</a> — Statizoid

About this data

Indicator
Meningococcal A conjugate (MENGA) vaccine immunization coverage (%) (WUENIC)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
33 places, 330 data points, 2016–2025
Last refreshed